How PILLAR Leverages Avita CareConnect to Grow Their Mission
A covered entity increased its 340B program sustainability and enhanced patient outcomes via a unique platform designed to foster engagement through data. Here’s how.
A covered entity increased its 340B program sustainability and enhanced patient outcomes via a unique platform designed to foster engagement through data. Here’s how.
The onsite pharmacy model can increase patient health equity, decrease provider overload, and move a covered entity’s mission. “If you take care of patients,” says Avita’s Mina Isaac, “everything else falls into place.”
Covered entities & their service providers act as healthcare safety nets for our most marginalized communities. They must unite to promote LGBTQ+ health equity.
From HIV to 340B, we gathered thought leaders’ insights on issues our covered entity partners care about the most. Read on for ideas to fuel your 2024 mission.
Is your covered entity team in search of reliable sources for 340B program news, advocacy campaigns, policies, events, and more? Then don’t miss this list.
Private insurance coverage is crucial to the health of both marginalized patients and covered entities. Here’s how CEs can tackle open enrollment for the win.
In the wake of abounding 340B changes, Dr. Christopher Hall gives a provider’s POV on the program’s impact and why sharing success stories is critical to its future.
Finding the right 340B partner is no walk in the park. Industry experts offer the top three considerations for selecting a solutions provider that will deliver.
Covered entities must constantly innovate their outreach efforts to encourage community HIV testing. Here are 12 testing event tips that move the needle.
Headed to the 340B Coalition Conference? Here’s how to get the most bang for your buck and walk away with ideas and contacts that will impact your mission.
A lack of strategic marketing can keep a covered entity from fulfilling its mission. Avita’s Glen Pietrandoni & Liz Eckert offer five tips for engaging patients.
As covered entities gear up for another year, former Surgeon General Dr. Jerome Adams offers actionable advice for keeping their eyes on the ball.
At the 340B Coalition Summer Conference, Avita Board Member Dr. Jerome Adams offered advice on supporting the drug discount program’s future. Read on for insights from 340B Report.
Confused by the latest 340B program developments? In this edition of The Take, Ted Slafsky breaks down current events & predicts what’s next.
Covered entities depend on 340B funding to serve vulnerable patients. Here are 7 insights on how to successfully navigate the program during challenging times.